INCELL
Innovative Life Science Solutions™
Menu
  • Home
    • Contact
    • Close
  • Products
    • Cart
    • Checkout
    • My Account
    • Close
  • Reg Med
    • Registrations Licenses & Certifications
    • Cell & Tissue Products
      • Regenerative & Stem Cells
      • Tissue-Derived Products
      • Reagents & Testing
      • INCELL Established Cell Lines
    • Tissue Collections & Kit Products
    • Storage of Cell & Tissue Products
    • Services: Manufacturing , Testing and R&D
      • Accelerated Product Development Services
      • Regenerative & Stem Cell Products
    • Close
  • Micro
    • Microbiology & Vaccine Products
      • Microbiology Testing
        • Sterility: GMP and USP Compliant
        • Microbial Bioburden
        • Endotoxin/Pyrogen Testing
        • Mycoplasma Testing
        • Antimicrobial & Microbiological Testing
        • Antimicrobials: New Product Testing In Vivo
    • Vaccines and Microbiology Products
      • Innovative Platforms, Tools and Vaccines
      • Microbiology & Vaccines Collaborations
    • Clinical Studies
    • Close
  • Clinical
    • Clinical Trials
    • Personalized Medicine
    • Close
  • About
    • Corporate
      • History
      • Mission
      • Registration, Licenses & Certificates
      • Memberships, Boards and Committees
    • Organization & Management
      • Board Members
        • Executive Managers
      • Key Alliances
        • Collaborative Business Model
    • Business Units & Activities
      • Regenerative Medicine
      • Media, Solutions & Kits
      • Microbiology & Vaccine Products
      • 503B Compounding & Formulation
    • Close
  • News
    • Close

Microbiology & Vaccine Products

Microbiology diagnostic, preventive and therapeutic products are developed by INCELL scientists, quality managers and manufacturing staff alone or with collaborators. The work includes GMP components manufacturing; complex formulation and packaging; identification and testing of live organisms, active ingredients, adjuvants, and excipients; evaluating natural and recombinant biotechnology-derived products; and testing of vaccines.

MicrobiologyVaccineProductsbiotechnology_word_play

Graphics provide from National Institute of Allergy and Infectious Diseases.

Vaccines and components in development include:

  • Bacteria
  • Viruses
  • Cell Substrates
  • Adjuvants & Protectants
  • GMP Media & Solutions
  • Non-Needle Delivery Technologies

Specific capabilities and activities include:

  • Manufacturing of vaccines as whole live, killed, subunit, or particulate organisms
  • Manufacturing of small and pilot scale sterile liquid fill products
  • Formulation and delivery components
  • QA and QbD in product manufacturing
  • Bioassays, potency, purity and QC release testing for certificates of analysis
  • Defining product labeling and packaging
  • Cost of goods analysis and pricing
  • Reproducibility, stability, product analysis
  • Diagnostic products and devices
  • Follow-on laboratory studies support
  • Consulting: Process and product development
  • Biotechnology Applications
    • Nucleic Acid Recombinant Technologies
    • Molecular Testing
    • Production Cells and Cell Lines
    • Monoclonal Antibodies
    • Diagnostics
    • Collaborative Planning for Clinical Study Design Testing

Follow Us

Recent Posts

  • INCELL and Charter Medical Announce Exclusive Global Distribution Agreement
  • Dr. Moyer Addresses Orthopedic Physicians at AAOM National Meeting
  • INCELL Global Expansion
  • 2016 World Stem Cell Summit: INCELL-BIOTURNKEY Joint Venture
  • INCELL Sponsors WSCS in December 2016

Contact INCELL Corporation LLC

12734 Cimarron Path (Directions)
San Antonio, Texas 78249
Tel: 210-877-0100|Toll-free: 800.364.1765
Fax: 210-877-0200

Terms & Conditions | Privacy | Contact

Copyright © 2016. All Rights Reserved.

Designed by WebAuthorings.